Biodegradation of the Steroid Progesterone in Surface Waters

Total Page:16

File Type:pdf, Size:1020Kb

Biodegradation of the Steroid Progesterone in Surface Waters Biodegradation of the Steroid Progesterone in Surface Waters A Thesis Submitted for the Degree of Doctor of Philosophy By Jasper Oreva Ojoghoro Institute of the Environment, Health and Societies May, 2017 Abstract Many studies measuring the occurrence of pharmaceuticals, understanding their environmental fate and the risk they pose to surface water resources have been published. However, very little is known about the relevant transformation products which result from the wide range of biotic and abiotic degradation processes that these compounds undergo in sewers, storage tanks, during engineered treatment and in the environment. Thus, the present study primarily investigated the degradation of the steroid progesterone (P4) in natural systems (rivers), with a focus on the identification and characterisation of transformation products. Initial work focussed on assessing the removal of selected compounds (Diclofenac, Fluoxetine, Propranolol and P4) from reed beds, with identification of transformation products in a field site being attempted. However, it was determined that concentrations of parent compounds and products would be too low to work with in the field, and a laboratory study was designed which focussed on P4. Focus on P4 was based on literature evidence of its rapid biodegradability relative to the other model compounds and its usage patterns globally. River water sampling for the laboratory-based degradation study was carried out at 1 km downstream of four south east England sewage works (Blackbirds, Chesham, High Wycombe and Maple Lodge) effluent discharge points. Suspected P4 transformation products were initially identified from predictions by the EAWAG Biocatalysis Biodegradation Database (EAWAG BBD) and from a literature review. At a later stage of the present work, a replacement model for EAWAG BBD (enviPath) which became available, was used to predict P4 degradation and results were compared. Samples were analysed using low resolution and accurate-mass time-of-flight mass spectrometers. Three degradation studies were conducted. Sampling for all studies was carried out at the same time in the year to minimize temporal variability in conditions and allow for effective comparison of results. Androgenic and progesterone yeast screens were carried out to assess the biological activity of transformation products. i Overall, the present study indicates that P4 degradation is relatively rapid in surface waters. Degradation followed the first order degradation kinetic and spiked P4 concentration (1,000 µg/L) was degraded below instrument detection limit (0.32 µg/L) in 72 h (3 days) in all locations except High Wycombe where 90% degradation occurred. Degradation half-life (t½) was approximately 7 hours in all sites except High Wycombe (29 hours) where some residual P4 (100 μg/L) was present after 72 hours. Overall, degradation rate was faster (0.1 hours) in the present study than those reported for algae (0.02-0.04 hours), thus, indicating that a more diverse microbial community was responsible for the breakdown of P4 observed in the present study. A number of putative degradation products were identified, including boldenone and (with less certainty) testosterone. The results highlighted that the transformation of progesterone can potentially create other classes of steroids, some of which may still be potent, and possess other types of biological activity. Although progesterone degraded to an androgen (boldenone) as shown by chemical analysis, the concentrations in the environment are unlikely to represent any immediate threat to aquatic resources, as results of the androgen screen did not show any androgenic activity when working at elevated (1,000 μg/L) initial progesterone concentrations. ii Declaration I hereby declare that the work described in this thesis were carried out independently by the author between 2014 and 2017 and has not been submitted anywhere for any award. Where other sources of information have been used, they have been appropriately referenced and all support received have been duly acknowledged. Jasper Oreva OJOGHORO May, 2017 iii Dedication This work is dedicated to Jehovah God for His abundant mercies, wisdom and grace upon me throughout my research. Also, to my lovely wife Mrs Victoria Oghenekaro Jasper-Ojoghoro and my adorable son Master Jason Oghenekome Jasper-Ojoghoro for love, devotion, support and encouragement. iv Acknowledgement I am profoundly grateful to the Nigeria Tertiary Education Trust Fund (TETFund) for providing the funding for this study. I am also grateful to the Delta State University, Abraka for facilitating my funding application and for granting my study leave application to complete the present study. I am also grateful to the Uduaghan led-administration of the Delta State Government and the 2010- 2015 board members of the Delta State Scholarship Board for providing the starting funds for this study. I am very grateful to my supervisor, Dr Mark D. Scrimshaw for going above and beyond in supervising me. His guidance, support, patience and encouragement, contributed immensely to the success of this study. I am also very grateful to Dr Chaudhary Abdul, my second supervisor for always giving the needed incite and perspective into my research. I am hugely indebted to Professor John Sumpter, who though very busy and not a member of my supervisory team, played a huge advisory role in my research. I am grateful to Dr Pablo Campo Moreno, Nicola Beresford, Julie Walker, Neil Brodigan, Amy Ferreira, Giles Drinkwater, Marta Straszkiewicz, Dr Belinda Huerta-Buitrago and Dr Alice Baynes for their technical support. I am also grateful to other staff in Environmental Sciences and my fellow PhD students who supported me at one point or the other. I am grateful to Professor (Mrs) M. Agbogidi, Professor (Mrs) N. Edema, Professor V. Peretomode, Professor S. Asagba, Professor H. Eghagha, Professor Atubi, Professor Anigala, Professor T. Akporhunor, Professor and Mrs O. Anomohanran, Professor C. Orubu, Dr C. Onogbosele, Mr and Mrs S. Joseph, Lt. K. Renner, Mr Sam Okolo, Mr C. Okwuokei, Mr and Mrs E. Uduboh, Mr and Mrs Odiete, Mr Afoke Evovo, Mr and Mrs A. Agbrara, Mr and Mrs G. Ogboru, Mr and Mrs A. Onwubiko, Mr and Mrs A. Adekanmi, Mr and Mrs V. Ajayi, Mr and Mrs B. Eradajire, Miss M. Denedo, Mrs O. Akpobi and Mrs G. Obi-Iyeke for their invaluable support. I am most dearly appreciative of my lovely wife Mrs Victoria Oghenekaro Jasper-Ojoghoro and my adorable son Master Jason Oghenekome Jasper-Ojoghoro for love, devotion, support and encouragement. My parents Mr and Mrs Vincent Ojoghoro, Mr and Mrs Collins Ogoru and siblings are also not left out for their prayerful support. v Table of Content Abstract ................................................................................................................................. i Declaration............................................................................................................................ iii Dedication ............................................................................................................................. iv Acknowledgement ................................................................................................................. v Table of Content ................................................................................................................... vi List of Figures ....................................................................................................................... x List of Tables ..................................................................................................................... xvii List of Abbreviations ............................................................................................................. xx List of Publications ............................................................................................................. xxv List of Equations ............................................................................................................... xxvi Chapter One: Introduction ..................................................................................................... 1 1.0 Introduction ............................................................................................................. 2 1.1 Sources of Pharmaceuticals in the Water Environment ........................................... 5 1.2 Research Aim and Objectives ............................................................................... 10 Chapter Two: Literature Review .......................................................................................... 12 2.0 Introduction ........................................................................................................... 13 2.1 Transformation of Pharmaceuticals ....................................................................... 16 2.1.1 The Potency of Natural and Synthetic Steroids and the Effects of Structural Transformation ............................................................................................................. 26 2.1.2 Role of TPs in Observed but Unexplained Biological Activity ......................... 28 2.1.3 Key Transformation Pathways in the Environment ......................................... 30 2.2 Approaches to Studying Degradation and Identification of TPs ............................. 40 2.2.1 Analytical Procedure for the Detection and Identification of TPs .................... 42 vi 2.3 Biotransformation Prediction
Recommended publications
  • Expression of Recombinant Human Androgen Receptor and Its Use for Screening Methods
    Institut für Physiologie FML Weihenstephan Technische Universität München Expression of recombinant human androgen receptor and its use for screening methods Ellinor Rose Sigrid Bauer Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. B. Hock Prüfer der Dissertation: Univ.-Prof. Dr. H. H. D. Meyer Univ.-Prof. Dr. H. Sauerwein (Rheinische Friedrich-Wilhelms-Universität Bonn) Die Dissertation wurde am 31.10.2002 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 03.12.2002 angenommen. Introduction Content 1. INTRODUCTION ..................................................................................................................................... 5 1.1. ENDOCRINE DISRUPTERS 5 1.2. ANDROGENS AND ANTIANDROGENS 7 1.2.1. DEFINITIONS 7 1.2.2. MODE OF ACTION 8 1.3. STRUCTURES OF ENDOCRINE DISRUPTERS 10 1.4. STRATEGIES FOR MONITORING ANDROGEN ACTIVE SUBSTANCES 13 1.4.1. IN VIVO METHODS 13 1.4.2. IN VITRO METHODS 15 1.5. OBJEKTIVE OF THE STUDIES 18 2. MATERIALS AND METHODS ................................................................................................................. 19 2.1. PREPARATION OF RECEPTORS 19 2.2. ASSAY SYSTEMS 19 2.2.1. IN SOLUTION AR ASSAY 19 2.2.2. IMMUNO-IMMOBILISED RECEPTOR ASSAY (IRA) 20 2.2.3. PR AND SHBG ASSAYS 21 2.2.4. DATA EVALUATION 21 2.3. ANALYTES 22 3. RESULTS AND DISCUSSION ................................................................................................................. 23 3.1. DEVELOPMENT OF NEW ASSAY SYSTEMS 23 3.1.1. BAR ASSAY 23 3.1.2. CLONING OF THE HUMAN AR AND PRODUCTION OF FUNCTIONAL PROTEIN 24 3.1.3. DEVELOPMENT OF A SCREENING ASSAY ON MICROTITRE PLATES (IRA) 25 3.2.
    [Show full text]
  • (Cyp19a1b-GFP) Zebrafish Embryos
    Screening Estrogenic Activities of Chemicals or Mixtures In Vivo Using Transgenic (cyp19a1b-GFP) Zebrafish Embryos Franc¸ois Brion1, Yann Le Page2, Benjamin Piccini1, Olivier Cardoso1, Sok-Keng Tong3, Bon-chu Chung3, Olivier Kah2* 1 Unite´ d’Ecotoxicologie in vitro et in vivo, Direction des Risques Chroniques, Institut National de l’Environnement Industriel et des Risques (INERIS), Verneuil-en- Halatte, France, 2 Universite´ de Rennes 1, Institut de Recherche Sante´ Environnement & Travail (IRSET), INSERM U1085, BIOSIT, Campus de Beaulieu, Rennes France, 3 Taiwan Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan Abstract The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b gene, encoding brain aromatase. This gene has two major characteristics: (i) it is only expressed in radial glial progenitors in the brain of fish and (ii) it is exquisitely sensitive to estrogens. Based on these properties, we demonstrate that natural or synthetic hormones (alone or in binary mixture), including androgens or progestagens, and industrial chemicals induce a concentration-dependent GFP expression in radial glial progenitors. As GFP expression can be quantified by in vivo imaging, this model presents a very powerful tool to screen and characterize compounds potentially acting as estrogen mimics either directly or after metabolization by the zebrafish embryo. This study also shows that radial glial cells that act as stem cells are direct targets for a large panel of endocrine disruptors, calling for more attention regarding the impact of environmental estrogens and/or certain pharmaceuticals on brain development. Altogether these data identify this in vivo bioassay as an interesting alternative to detect estrogen mimics in hazard and risk assessment perspective.
    [Show full text]
  • Part I Biopharmaceuticals
    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
    [Show full text]
  • 伊域化學藥業(香港)有限公司 Cyclopentyl Substituted Compounds
    ® 伊 域 化 學(香 藥 香 港) 業 港有 有 限 限 公 公 司 司 YICK-VIC CHEMICALS & PHARMACEUTICALS (HK) LTD Rm 1006, 10/F, Hewlett Centre, Tel: (852) 25412772 (4 lines) No. 52-54, Hoi Yuen Road, Fax: (852) 25423444 / 25420530 / 21912858 Kwun Tong, E-mail: [email protected] YICKYICK----VICVICVICVIC 伊域伊域伊域 Kowloon, Hong Kong. Site: http://www.yickvic.com Cyclopentyl Substituted Compounds Product Code CAS Product Name CC-0052BA 39746-00-4 (-)-COREY LACTONE BENZOATE CC-3702AD 1211-29-6 (-)-METHYL JASMONATE SPI-4467C 87269-86-1 (-)-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID HYDROCHLORIDE SPI-4467A 93779-30-7 (+/-)-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID HYDROCHLORIDE SPI-2956FG 142217-81-0 (1S,3R,4S)-2-AMINO-9-(4-BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLIDENECYCLOPENTYL-3H-PURINE-9-ONE SPI-2956FJ 142217-78-5 (2R,3S,5S)-3-(BENZYLOXY)-5-[2-[[(4-METHOXYPHENYL)DIPHENYLMETHYL]AMINO]-6-(PHENYLMETHOXY)-9H-PURIN-9-Y L]-2-(BENZYLOXYMETHYL)CYCLOPENTANOL SPI-1560DH 4167-77-5 1,1-CYCLOPENTANEDICARBOXYLIC ACID DIETHYL ESTER SPI-2808C 5763-44-0 1,2-CYCLOPENTANE DICARBOXIMIDE CC-1957B 1222-05-5 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYLCYCLOPENTA[G]-2-BENZOPYRAN SPI-1246B 3859-41-4 1,3-CYCLOPENTANEDIONE SPI-1955AA 646-06-0 1,3-DIOXOLANE SPI-3082AA 54078-29-4 1,8-DIAZAFLUOREN-9-ONE UNIE-13864 564-35-2 11-KETOTESTOSTERONE SPI-0098CA 640-87-9 17-ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 21-ACETATE UNIE-13126 302-76-1 17ALPHA-METHYL-17BETA-ESTRADIOL UNIE-14695 3563-27-7 17BETA-DIHYDROQUILIN UNIE-2836 10316-79-7 1-AMINO-1-CYCLOPENTANEMETHANOL SPI-3077CB 61379-64-4 1-AMINO-4-CYCLOPENTYLPIPERAZINE
    [Show full text]
  • A New Highly Specific and Robust Yeast Androgen Bioassay for the Detection of Agonists and Antagonists
    Anal Bioanal Chem (2007) 389:1549–1558 DOI 10.1007/s00216-007-1559-6 ORIGINAL PAPER A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists Toine F. H. Bovee & Richard J. R. Helsdingen & Astrid R. M. Hamers & Majorie B. M. van Duursen & Michel W. F. Nielen & Ron L. A. P. Hoogenboom Received: 27 April 2007 /Revised: 3 July 2007 /Accepted: 15 August 2007 / Published online: 12 September 2007 # Springer-Verlag 2007 Abstract Public concern about the presence of natural and very specific and also suited to detect compounds that have anthropogenic compounds which affect human health by an antiandrogenic mode of action. modulating normal endocrine functions is continuously growing. Fast and simple high-throughput screening methods Keywords Antagonists . Brominated flame retardants . for the detection of hormone activities are thus indispens- Crosstalk . Metabolism . Receptor . Saccharomyces able. During the last two decades, a panel of different in vitro cerevisiae assays has been developed, mainly for compounds with an estrogenic mode of action. Here we describe the develop- ment of an androgen transcription activation assay that is Introduction easy to use in routine screening. Recombinant yeast cells were constructed that express the human androgen receptor There is concern that chemicals in our food, water, and and yeast enhanced green fluorescent protein (yEGFP), the environment affect human health by disrupting normal latter in response to androgens. Compared with other endocrine function, possibly leading to reproductive failure reporters, the yEGFP reporter protein is very convenient in humans and tumors in sensitive tissues [1, 2]. This because it is directly measurable in intact living cells, i.e., relates to chemicals with previously unknown hormonal cell wall disruption and the addition of a substrate are not properties, like certain pesticides and plasticizers, but also needed.
    [Show full text]
  • Steroids and Other Appearance and Performance Enhancing Drugs (Apeds) Research Report
    Research Report Revised Febrero 2018 Steroids and Other Appearance and Performance Enhancing Drugs (APEDs) Research Report Table of Contents Steroids and Other Appearance and Performance Enhancing Drugs (APEDs) Research Report Introduction What are the different types of APEDs? What is the history of anabolic steroid use? Who uses anabolic steroids? Why are anabolic steroids misused? How are anabolic steroids used? What are the side effects of anabolic steroid misuse? How does anabolic steroid misuse affect behavior? What are the risks of anabolic steroid use in teens? How do anabolic steroids work in the brain? Are anabolic steroids addictive? How are anabolic steroids tested in athletes? What can be done to prevent steroid misuse? What treatments are effective for anabolic steroid misuse? Where can I get further information about steroids? References Page 1 Steroids and Other Appearance and Performance Enhancing Drugs (APEDs) Research Report Esta publicación está disponible para su uso y puede ser reproducida, en su totalidad, sin pedir autorización al NIDA. Se agradece la citación de la fuente, de la siguiente manera: Fuente: Instituto Nacional sobre el Abuso de Drogas; Institutos Nacionales de la Salud; Departamento de Salud y Servicios Humanos de los Estados Unidos. Introduction Appearance and performance enhancing drugs (APEDs) are most often used by males to improve appearance by building muscle mass or to enhance athletic performance. Although they may directly and indirectly have effects on a user’s mood, they do not produce a euphoric high, which makes APEDs distinct from other drugs such as cocaine, heroin, and marijuana. However, users may develop a substance use disorder, defined as continued use despite adverse consequences.
    [Show full text]
  • TGA Review of Hgps
    A REVIEW TO UPDATE AUSTRALIA’S POSITION ON THE HUMAN SAFETY OF RESIDUES OF HORMONE GROWTH PROMOTANTS (HGPs) USED IN CATTLE Prepared by Chemical Review and International Harmonisation Section Office of Chemical Safety Therapeutic Goods Administration of the Department of Health and Ageing Canberra July 2003 A draft of this report was tabled at the 25th Meeting of the Advisory Committee on Pesticides and Health (ACPH), held in Canberra on the 1st May 2003. The report was subsequently endorsed out-of-session by the ACPH. Hormone Growth Promotants TABLE OF CONTENTS ABBREVIATIONS ................................................................................................................................................................4 EXECUTIVE SUMMARY ..................................................................................................................................................7 INTRODUCTION..................................................................................................................................................................9 HEALTH CONCERNS ASSOCIATED WITH HGP S................................................................................................................9 DIFFICULTIES ASSOCIAT ED WITH ASSESSING THE SAFETY OF HGPS.........................................................................10 RISK ASSESSMENTS OF HGP S .........................................................................................................................................10 PURPOSE OF THE CURRENT
    [Show full text]
  • Analytical Reference Standards
    Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation.
    [Show full text]
  • WO 2012/148570 Al 1 November 2012 (01.11.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/148570 Al 1 November 2012 (01.11.2012) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, A61L 27/14 (2006.01) A61P 17/02 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, C08L 101/16 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, PCT/US20 12/027464 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 2 March 2012 (02.03.2012) SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, 13/093,479 25 April 201 1 (25.04.201 1) US UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant (for all designated States except US): DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, WARSAW ORTHOPEDIC, INC.
    [Show full text]
  • Avaliação Do Teste De Micronúcleo Em Linfócitos Para Uso Como Biomarcador De Risco De Câncer Em Usuários De Esteroides Anabolizantes Androgênicos
    UNIVERSIDADE ESTADUAL DE FEIRA DE SANTANA PROGRAMA DE PÓS-GRADUAÇÃO EM BIOTECNOLOGIA LEONARDO DA CUNHA MENEZES SOUZA AVALIAÇÃO DO TESTE DE MICRONÚCLEO EM LINFÓCITOS PARA USO COMO BIOMARCADOR DE RISCO DE CÂNCER EM USUÁRIOS DE ESTEROIDES ANABOLIZANTES ANDROGÊNICOS Feira de Santana, BA 2013 LEONARDO DA CUNHA MENEZES SOUZA AVALIAÇÃO DO TESTE DE MICRONÚCLEO EM LINFÓCITOS PARA USO COMO BIOMARCADOR DO RISCO DE CÂNCER EM USUÁRIOS DE ESTEROIDES ANABOLIZANTES ANDROGÊNICOS Dissertação apresentada ao Programa de Pós-graduação em Biotecnologia, da Universidade Estadual de Feira de Santana como requisito parcial para obtenção do título de Mestre em Biotecnologia. Orientadora: Profa. Dr. Eneida de Moraes Marcílio Cerqueira Feira de Santana, BA 2013 Aos meus pais com carinho AGRADECIMENTOS A Deus pela serenidade e coragem em momentos adversos; Ao meu pai e à minha mãe, por proporcionarem sempre um ambiente fértil ao aprendizado e à gentileza; À profa Eneida de Moraes Marcílio Cerqueira pela orientação segura, disponibilidade incondicional, e pelo carinho durante todos estes anos; À Maíza Alves Lopes pela grande ajuda e agradável companhia durante o desenvolvimento do trabalho, tornando menos árdua à empreitada; Ao professor José Roberto Cardoso Meireles pelos ensinamentos preciosos e grande ajuda ao longo de toda minha formação; À Luciara Alves da Cruz, pela disponibilidade para com as coletas, sem a qual este trabalho não seria possível; À Daisy Maria Favero Salvadori, à Luciana Maria Feliciano e à equipe da UNESP de Botucatu por terem me recebido tão
    [Show full text]
  • Characterisation of Chemical and Pharmacological Properties of New Steroids Related to Doping of Athletes
    In: W Schänzer, H Geyer, A Gotzmann, U Mareck (eds.) Recent Advances In Doping Analysis (14). Sport und Buch Strauß - Köln 2006 C. Ayotte, D. Goudreault, D. Cyr and J. Gauthier1, P. Ayotte and C. Larochelle2, and D. Poirier3 Characterisation of chemical and pharmacological properties of new steroids related to doping of athletes 1INRS-Institut Armand-Frappier, Pointe Claire, Canada 2Institut de Santé publique de Québec, U. Laval, Québec, Canada 3Centre de recherche en chimie médicinale, U. Laval, Québec, Canada In the USA, a female cyclist, T. Thomas, was banned for the use of norbolethone, a steroid which has been studied by the pharmaceutical industry in the 60s but not commercialised1. Later in 2004, following the characterisation of THG2 from a oily residue given to the American testing authorities, and in collaboration with the international athletic federation, several elite athletes’ samples were tested and found to contain that “designer” steroid. The properties of tetrahydrogestrinone were subsequently studied; it appears that THG is a potent androgen and progestin3. Public comments made by individuals involved in the “Balco” scandal were adding to the information coming from other sources, mainly informants, to the effect that other “designer”, potent and undetecTable steroids have been prepared and would be available to certain athletes. This has become a certainty in December 2003, following a seizure at the Canadian border of hGH, and two steroid-products one of which found to be THG. The identification of the second one, DMT (17α-methyl-5α-androst-2-en-17β-ol major isomer along with the 3-en isomer), is the subject of the first part of this work; picture of the bottle seized is shown at Figure 1.
    [Show full text]
  • Neural Control of Human Movement
    97818_ch19.qxd 8/4/09 4:16 PM Page 376 CHAPTER 19 Neural Control of Human Movement CHAPTER OBJECTIVES ➤ Draw the major structural components of the ➤ Outline motor unit facilitation and inhibition and brain, including the four lobes of the cerebral the contribution of each to exercise performance cortex and responsiveness to resistance training ➤ Discuss specific pyramidal and extrapyramidal ➤ Discuss variations in twitch characteristics, resist- tract functions ance to fatigue, and tension development in the different motor unit categories ➤ Diagram the anterior motor neuron and discuss its role in human movement ➤ Describe mechanisms that adjust force of muscle action along the continuum from slight to ➤ Draw and label the basic components of a maximum reflex arc ➤ Define fatigue and discuss factors that act and ➤ Define the terms (1) motor unit, (2) neuromuscular interact to induce neuromuscular fatigue junction, and (3) autonomic nervous system ➤ List and describe functions of the proprioceptors ➤ Summarize the events in motor unit excitation within joints, muscles, and tendons prior to muscle action 376 97818_ch19.qxd 8/4/09 4:16 PM Page 377 CHAPTER 19 Neural Control of Human Movement 377 The effective application of force during complex learned Brainstem movements (e.g., tennis serve, shot put, golf swing) depends on a series of coordinated neuromuscular patterns, not just on The medulla, pons, and midbrain compose the brain- muscle strength. The neural circuitry in the brain, spinal cord, stem. The medulla, located immediately above the spinal and periphery functions somewhat similar to a sophisticated cord, extends into the pons and serves as a bridge between computer network.
    [Show full text]